JOINDER AGREEMENTJoinder Agreement • September 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations
Contract Type FiledSeptember 1st, 2022 Company IndustryThe undersigned agrees, effective as of August 19, 2022, to become a party to the Joint Filing and Advocacy Agreement, dated May 31, 2022 (as it may be amended or restated from time to time, the “Joint Filing Agreement”), between (a) Concord IP2 Ltd., Elderhill Corporation and David Delaney; (b) Leonite Capital, LLC and Avi Geller; and (c) Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP and Eric Shahinian.